<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>14635412</identifier>
<setSpec>0556-6177</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Mejía, S</dc:author>
<dc:author>Cordero, A</dc:author>
<dc:author>Alegría, E</dc:author>
<dc:author>Velasco, A</dc:author>
<dc:author>Raymondi, D Martín</dc:author>
<dc:description xml:lang="en">Heart failure has become a major public health problem. About 2-3% of people over 65 years suffer from Heart Failure. A huge amount of money is spent every year treating problems connected with this syndrome. In this paper we analyse randomised prospective trials which support the use of beta-blockers in these patients. We also analyse the benefits of this treatment and some special considerations concerning the use of these drugs.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2003 Apr-Jun </dc:date>
<dc:title xml:lang="es">Utilidad de los beta-bloqueantes en el tratamiento de la insuficiencia cardiaca crónica.</dc:title>
<dc:title xml:lang="en">[Utility of beta-blockers in the treatment of chronic heart failure].</dc:title>
<dc:publisher>Revista de medicina de la Universidad de Navarra</dc:publisher>
</metadata>
</record>
</pubmed-document>
